Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases

Author(s): Piyoosh A. Sharma, Rahul Maheshwari, Muktika Tekade, Rakesh Kumar Tekade

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 30 , 2015

Become EABM
Become Reviewer
Call for Editor


The increasing prevalence and complexity of cardiovascular diseases demand innovative strategies for diagnostic and therapeutic applications to improve patient care/prognoses. Additionally, various factors constrain present cardiovascular therapies, including low aqueous drug solubility, early metabolism, short half-life and drug delivery limitations. The efficient treatment of cardiovascular diseases requires improvement of traditional drug delivery systems. This can be accomplished by using novel nanomaterial that can incorporate diverse bio-actives along with diagnostic agents in a single carrier, referred to as theranostics. This review discusses the state of the art in the applications to diagnosis and therapy of innovative, nanomaterial- based strategies such as lipid based carriers, nanocapsules, magnetic nanoparticles, gold nanoparticles, protein conjugated nanoparticles, dendrimers and carbon-based nanoformulations with a special emphasis on how they can contribute to improving the management of cardiovascular disease.

Keywords: Cardiovascular diseases, nanomaterials, liposomes, gold nanoparticles, magnetic nanoparticles, carbon nanotubes, theranostics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [4465 - 4478]
Pages: 14
DOI: 10.2174/1381612821666150910113031
Price: $65

Article Metrics

PDF: 35